MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ EXK¿ DNA-3; CLINICAL SAMPLE CONCENTRATOR

Model Number 442821

Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Date 04/13/2022

Event Type  malfunction  

Manufacturer Narrative

A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.

Event Description

It was reported that while using bd max¿ exk¿ dna-3 the customer observed biological contamination of several kits.This event occurred 2 time(s).There is no indication that false results were reported to health care practitioners.There is no indication of patient impact.The following information was provided by the initial reporter: "customer reports widespread contamination across several kits of 442821 - lot #2025615.", "i can confirm that the new lot (2025615) was positive for enterococcus faecalis in two replicate water blank samples.".

Manufacturer Narrative

H6: investigation summary: the complaint investigation for contamination when using bd max exk dna-3 usa kit (ref #442821) from lot 2025615 was performed by the review of manufacturing records, analysis of customer data and verification of complaints history.Review of the manufacturing records of the bd max exk dna-3 usa kit lot indicated that the lot was manufactured according to specifications and met performance requirements.Customer complained about widespread contamination across several kits of bd max exk dna-3 usa kit lot 2025615.According to customer, positive e.Faecalis results were obtained on blank and environmental monitoring samples.Customer provided runs for investigation (runs 1620 and 1627 from instrument ct1313).In run #1627, there is one blank sample positive for e.Faecalis and in run #1620, there are two e.Faecalis positive results (position a5 and position a7).Manual pcr curves adjudication of the three e.Faecalis positive results in the runs provided revealed late and low, but true amplification of the target.Nevertheless, manual curve adjudication has limitations and visual examination of pcr curves for low signal is a conservative assessment of the data.The bd max exk dna-3 is an open system reagents kit intended to extract dna from swab specimens in universal transport media (utm) or neat urine specimens.The bd max exk dna-3 has not been validated for use with any specific test method, and as such, it is not possible for bd to test for all possible presence of target that could potentially impact assays developed by customers.Customers need to validate and use appropriate controls, in accordance with country, federal, provincial, state, local and/or accrediting organization guidelines, regulations and standards.The investigation conducted by bd identified the root-cause of these positive e.Faecalis results as contaminated lots of enzymes used in the manufacturing of the extraction tubes.The investigation also allowed to detect contamination of m.Morganii target.The enzyme supplier was informed of this contamination and an investigation is ongoing by the supplier.There is no indication of an increase in complaints for contamination on bd max exk dna-3 usa kit lot 2025615.The root cause was identified as a raw material contamination, investigation is still ongoing to determine the exact cause at the supplier.Bd confirms the complaint based on the investigation that was performed.

Event Description

It was reported that while using bd max¿ exk¿ dna-3 the customer observed biological contamination of several kits.This event occurred 2 time(s).There is no indication that false results were reported to health care practitioners.There is no indication of patient impact.The following information was provided by the initial reporter: "customer reports widespread contamination across several kits of 442821 - lot #2025615.", "i can confirm that the new lot (2025615) was positive for enterococcus faecalis in two replicate water blank samples.".

• Brand Name: BD MAX¿ EXK¿ DNA-3
• Type of Device: CLINICAL SAMPLE CONCENTRATOR
• Manufacturer (Section D): GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS); 2555 blv. du parc techn; quebec
• Manufacturer (Section G): GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS); 2555 blv. du parc techn; quebec
• Manufacturer Contact: phillip emmert ; 9450 south state street; sandy, UT 84070 ; 8015296192
• MDR Report Key: 14350237
• MDR Text Key: 293878500
• Report Number: 3007420875-2022-00023
• Device Sequence Number: 1
• Product Code: JJH
• UDI-Device Identifier: 00382904428211
• UDI-Public: 00382904428211
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: NA
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Other,User Facility
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date: 06/15/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 05/10/2022
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Other
• Device Expiration Date: 08/05/2023
• Device Model Number: 442821
• Device Catalogue Number: 442821
• Device Lot Number: 2025615
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Date Manufacturer Received: 06/15/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 01/25/2022
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1